大数跨境

文献速递丨SCI 高分文献(IF值:14.6)二元焦亡放大自组装前药纳米药物增强免疫原性并抑制卵巢癌腹腔转移

文献速递丨SCI 高分文献(IF值:14.6)二元焦亡放大自组装前药纳米药物增强免疫原性并抑制卵巢癌腹腔转移 金源康生物
2026-02-06
0

高分文献速递


客户单位:南方医科大学珠江医院


期刊:Acta Pharmaceutica Sinica B


影响因子(IF):14.6

文章题目:

Binary pyroptosis-amplified self-assembling prodrug nanomedicine enhances immunogenicity and inhibits abdominal metastasis in ovarian cancer

文章摘要:


Ovarian cancer remains a formidable therapeutic challenge due to its high propensity for abdominal metastasis, recurrence, and the presence of an immunosuppressive tumor microenvironment. To overcome these obstacles, we developed a self-assembled nanoplatforms (OSN) by integrating a near-infrared semiconducting polymer with an oxaliplatin(IV) prodrug. This multifunctional design enables a synergistic triple-modality therapy—photothermal therapy (PTT), photodynamic therapy (PDT), and chemotherapy—within a single nanoparticle, effectively enhancing immunogenic cell death (ICD) and systemic antitumor immunity. Upon laser irradiation, OSN generates localized hyperthermia and reactive oxygen species. These effects synergistically enhance oxaliplatin activation and tumor penetration while triggering pyroptosis through dual caspase-1-mediated and caspase-3-dependent pathways. This robust pyroptotic response amplifies the release of damage-associated molecular patterns (e.g., ATP, HMGB1) and pro-inflammatory cytokines (e.g., IL-18, IL-1β), thereby remodeling the immunosuppressive microenvironment, promoting dendritic cell maturation, and facilitating cytotoxic T-cell infiltration. In murine ovarian cancer models, OSN achieved over 90% tumor suppression, significantly outperforming monotherapies. Notably, this nanoplatform establishes long-term immune memory, effectively reducing the risk of tumor relapse. By concurrently targeting immunogenic barriers and metastatic progression through multimodal mechanisms, OSN represents a paradigm-shifting strategy with high clinical translatability for the treatment of aggressive ovarian malignancies.

原文链接:

https://doi.org/10.1016/j.apsb.2025.10.042

引用产品及培养细胞:FBS-301 ID8

【声明】内容源于网络
0
0
金源康生物
金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
内容 0
粉丝 0
金源康生物 金源康生物是一家专注动物血清、培养基、疫苗佐剂、细胞库及周边产品等研发与生产应用的国家级高新技术企业,奥普赛生物为金源康所属子品牌。咨询热线:400-880-5811,官方网址:www.nmjyk.com
总阅读0
粉丝0
内容0